/channels/news_feeds/all/term/Allergan/rss en /channels/news/treatment-dry-eye-disease-based-mcgill-research-257072 <div class="field field-name-body field-type-text-with-summary field-label-hidden"><div class="field-items"><div class="field-item even"><p><span>The discovery that tavilermide  induces the production of mucin, a crucial lubricant in tears, offers hope of relief to people who suffer from chronic dry eye disease. The invention and the development of a drug based on this small molecule was made by the team of Dr. H. Uri Saragovi, Senior Investigator at the Lady Davis Institute (LDI) at the Jewish General Hospital and Professor of Pharmacology at ±«ÓãÖ±²¥.</span></p></div></div></div><div class="field field-name-field-primary-image field-type-image field-label-hidden"><div class="field-items"><div class="field-item even"><img class="no-float" src="/channels/files/channels/styles/wysiwyg_medium/public/channels/image/thinkstock-eyedrop-eye.jpg?itok=QCllZpbR" width="160" height="107" /></div></div></div><div class="field field-name-field-published-date field-type-datestamp field-label-hidden"><div class="field-items"><div class="field-item even"><div class="custom-multi-date"><div class="multi-date first"><span class="label">Published: </span><span class="day">3 </span><span class="month">December </span><span class="year">2015</span></div></div></div></div></div> Thu, 03 Dec 2015 20:11:35 +0000 webfull 114402 at /channels